STONY BROOK, N.Y., Dec. 8 /PRNewswire-FirstCall/ -- Applied DNA
Sciences, Inc. (OTC Bulletin Board: APDN), a DNA security solutions
company, today announced that it has entered into consulting agreements
with two experts renowned in their fields of work. John Twilley and Thomas
A. Nicolette both bring to APDN years of relevant experience which will be
used by APDN as it grows its customer base and pursues new and existing
markets for its SigNature(TM) Program.
John Twilley is renowned in the field of art conservation with over
thirty years of experience. Mr. Twilley has written numerous publications
and over 600 unpublished scientific reports on the conservation of art and
related topics. Mr. Twilley has held research positions in industry as well
as serving as Conservation Scientist at the J. Paul Getty Museum. He held
the position of Senior Research Scientist at the Conservation Center of the
Los Angeles County Museum of Art and taught art and artifacts conservation
at the graduate level within the University of California for twenty years.
Mr. Twilley is renowned for his expertise in authentication and
conservation of artworks, with a recent emphasis on Asian Art. Mr. Twilley
currently has a successful independent practice in conservation science and
is assisting APDN in the area of art and collectibles as it pursues this
important target market.
Fine art and collectibles are especially vulnerable to counterfeiting,
forgeries and fraud. APDN believes that its SigNature(TM) DNA Markers can
be safely embedded directly in all forms of artwork and collectibles and
thus can be used to designate and authenticate these valuables. These DNA
Markers can also be embedded in any original supporting documentation
related to the artwork or collectibles, in the signature of the artist and
in any other relevant material that would provide provenance. Mr. Twilley's
expertise in art conservation will assist APDN in the fine art and
collectibles market where material compatibility and longevity issues are
paramount and where unique security concerns exist, thereby helping to
penetrate this important market segment.
Thomas A. Nicolette brings over thirty years of experience with
security solutions companies to his association with APDN. Having
previously held senior management and Board of Director positions in the
Authentication and Anti-Shoplifting Industries, Mr. Nicolette brings his
knowledge of the industry and the competitive landscape to APDN. Using this
knowledge and experience, Mr. Nicolette will be assisting APDN in
developing new customers for APDN's SigNature(TM) Program in its identified
target markets worldwide. These markets initially include fine wine, art
and collectibles, consumer products, digital and recording media,
pharmaceuticals and homeland security.
Dr. James A. Hayward, CEO of APDN, stated, "We are pleased to be
working with these renowned gentlemen and we look forward to the advice and
expertise they bring to APDN. Their knowledge and understanding of key
issues will be helpful as we further penetrate the target markets that APDN
has already identified and they will be instrumental in identifying new
About Applied DNA Sciences, Inc.
Applied DNA Sciences, Inc. (APDN) provides botanical DNA encryption,
embedment and authentication solutions that can help protect companies,
governments and consumers from counterfeiting, fraud, piracy, product
diversion, identity theft and unauthorized intrusion into physical
locations and databases. Our common stock is registered under Section 12(g)
of the Securities Exchange Act of 1934 and is listed on the
Over-The-Counter Bulletin Board under the symbol "APDN." Contact: Debbie
Bailey, Applied DNA Sciences, Inc., 25 Health Sciences Drive, Stony Brook,
New York 11790; Tel: 631-444- 8090; Fax: 631-444-8848 http://www.ADNAS.com.
The statements made by Applied DNA Sciences, Inc. may be
forward-looking in nature and are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements describe the Company's future plans,
projections, strategies and expectations, and are based on assumptions and
involve a number of risks and uncertainties, many of which are beyond the
control of Applied DNA Sciences, Inc. Actual results could differ
materially from those projected due to our short operating history, limited
market acceptance, market competition and various other factors detailed
from time to time in Applied DNA Sciences' SEC reports and filings,
including our Registration Statement on Form SB-2 as amended, our Annual
Report on Form 10-KSB, filed on January 12, 2006, our subsequent Quarterly
Reports on Form 10-QSB, and our Current Reports on Form 8-K. The Company
undertakes no obligation to update publicly any forward-looking statements
to reflect new information, events or circumstances after the date hereof
to reflect the occurrence of unanticipated events.
SOURCE Applied DNA Sciences, Inc.